Patent Yard Sign in
Canadian application, no grantCanada

Materials and methods relating to nucleic acid amplification and profiling

CA 2425904 A1 · Owner: Cancer Research Technology Limited · Inventors: Guldberg, Per

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides improved methods for determining the methylation profile of a nucleic acid sequence and for determining one or more base changes in the target nucleic acid sequence as compared to a corresponding control sequence. The methods are one-step methods which can be incorporated with known amplification techniques such as PCR. The invention also provides methods for determining changes in nucleic acid sequences either via their methylation profile or owing to mutations of one or more bases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 23, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 23, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 23, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 23, 2001
GrantedNo grant recorded
Term endedOctober 23, 2021
Patent numberCA 2425904 A1
Classification (IPC)C12Q1/68

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedOct 23, 2001Term endedOct 23, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.